Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s traded shares stood at 0.66 million during the last session, with the company’s beta value hitting -0.54. At the close of
In the last trading session, 1.0 million Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) shares changed hands as the company’s beta touched -0.52. With the company’s per share
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) has a beta value of -0.55 and has seen 1.22 million shares traded in the last trading session. The company, currently
During the last session, Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s traded shares were 0.81 million, with the beta value of the company hitting -0.55. At the end
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s traded shares stood at 1.15 million during the last session, with the company’s beta value hitting -0.50. At the close of
In the last trading session, 1.16 million Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) shares changed hands as the company’s beta touched -0.50. With the company’s per share
During the last session, Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s traded shares were 0.44 million, with the beta value of the company hitting -0.53. At the end
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s traded shares stood at 0.68 million during the last session, with the company’s beta value hitting -0.65. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
